Medical Technology

Openwater's portable stroke detection tool enhances EMS capabilities, improving rapid diagnosis and treatment for severe strokes in emergency settings.

Guardant Health's Shield multi-cancer screening test detects multiple cancer types with a single blood draw, promising early diagnosis for various cancers.

BiVACOR's magnetic artificial heart gains FDA Breakthrough Device status, promising a revolutionary solution for severe heart failure patients.

Reflow Medical's Spur Stent System gains FDA clearance, offering treatment options for chronic limb-threatening ischemia with its retrievable design.

Moximed initiates a trial for its MISHA Knee System, an alternative treatment for knee osteoarthritis, promising pain relief and improved mobility.

Cloud computing can transform medical practices by offering cost-effective, scalable solutions while ensuring HIPAA compliance and enhancing patient care.

Leveraging intelligent automation to streamline workflows, reduce errors and elevate patient outcomes.

Physicians' involvement in technology design enhances care delivery, reduces friction, and builds trust, leading to better patient outcomes and efficient health systems.

GlobalData report says hospitals may be accelerating purchases of certain medical devices

Tenovi's new blood pressure monitor enhances stroke prevention by enabling early detection of hypertension and irregular heartbeats through remote patient monitoring.

Aptar Digital Health and AstraZeneca collaborate to revolutionize chronic kidney disease detection using AI algorithms in eye exams, enhancing early diagnosis.

Medtronic announces a diabetes business spinoff to enhance focus on growth areas, aiming for improved financial performance and shareholder value.

ReGelTec's HYDRAFIL System offers a minimally invasive treatment for chronic low back pain, promising significant pain relief and improved function.

Atia Vision's OmniVu lens system promises a breakthrough in cataract surgery with enhanced vision restoration.

U.S. tariffs are disrupting European medtech growth, forcing firms to adapt supply chains and prioritize cost optimization amid rising challenges and uncertainties.

Fujirebio Diagnostics’ test, which received 510k clearance Friday, will “assist physicians and patients to obtain an AD diagnosis in early stages of the disease.”

The VivAer procedure offers lasting relief for nasal obstruction, transforming NAO treatment with its minimally invasive approach and impressive results.

Consider these six proven ways physicians and other clinicians can lower costs and improve quality of care.

Medtech CEO warns senate that tariffs could undermine health care and innovation

Synchron integrates brain-computer interface technology with Apple devices, enabling thought-controlled access for individuals with motor impairments.

Veradigm leverages AI to enhance real-world evidence for GLP-1 drugs, revealing insights on patient adherence, side effects, and treatment outcomes.

AccurKardia's AccurECG wins "Best New Technology Solution for ECG," revolutionizing cardiac diagnostics with AI-driven, real-time ECG analysis for better patient outcomes.

Osteoboost introduces a groundbreaking FDA-cleared device for osteoporosis, offering innovative, non-invasive therapy to enhance bone health and prevent fractures.

Imperative Care enhances stroke treatment with Zoom DuoPort, enabling efficient dual aspiration for faster, more effective thrombectomy procedures.

BrightHeart's FDA-cleared AI platform enhances fetal heart screenings, improving detection of congenital heart defects during ultrasounds with real-time analysis.